Many patients remain on the 2.5 mg or 5 mg starting doses, which are primarily for tolerability rather than therapeutic effect, and do not reach the 10-15 mg weekly doses where maximal efficacy typically occurs
Reconstruction precision isn't perfectionism
Treatments tailored toward the needs of individual patients based on their CKD stage and microbiome profiles via the application of different -omics approaches such as microbiome analysis, metabolomics, metagenomics, metaproteomics, nutrigenomics, and others enable the application of suitable dietary requirements, physical activity, and/or biotic supplementation that will be most beneficial to them via modulation of the microbiota, reduction of uremic toxins and inflammation, and slowing CKD progression ultimately leading to an improvement in their cognitive health and overall quality of life
In peptide research, this relationship is often described as a 1+1=3 effect due to the supra-additive nature of the secretagogues
Roe DR, Cheatham TE (2013) PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data
